首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >From the Cover: Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling
【2h】

From the Cover: Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling

机译:从封面:Mpl-/-小鼠的抑制子筛选:c-Myb突变在血小板生成素信号不存在的情况下导致血小板的超生理生成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genetic screens in lower organisms, particularly those that identify modifiers of preexisting genetic defects, have been used successfully to order components of complex signaling pathways. To date, similar suppressor screens have not been used in vertebrates. To define the molecular pathways regulating platelet production, we have executed a large-scale modifier screen with genetically thrombocytopenic Mpl-/- mice by using N-ethyl-N-nitrosourea mutagenesis. Here we show that mutations in the c-Myb gene cause a myeloproliferative syndrome and supraphysiological expansion of megakaryocyte and platelet production in the absence of thrombopoietin signaling. This screen demonstrates the utility of large-scale N-ethyl-N-nitrosourea mutagenesis suppressor screens in mice for the simultaneous discovery and in vivo validation of targets for therapeutic discovery in diseases for which mouse models are available.
机译:在低等生物中,特别是那些能够识别先前存在的遗传缺陷修饰物的生物,已经成功地使用了遗传筛选来对复杂信号通路的成分进行排序。迄今为止,在脊椎动物中还没有使用类似的抑制器筛选。为了定义调节血小板生成的分子途径,我们使用N-乙基-N-亚硝基脲诱变技术对遗传性血小板减少性Mpl -/-小鼠进行了大规模修饰筛选。在这里,我们显示c-Myb基因中的突变会导致骨髓增生异常综合征以及在没有血小板生成素信号传导的情况下巨核细胞和血小板生成的超生理学扩展。此屏幕展示了在小鼠中可大规模发现的N-乙基-N-亚硝基脲诱变抑制剂屏幕在小鼠中同时发现和体内验证治疗性靶标的实用性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号